Loading…
Pharmaceutical Market Access Act of 2009
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 4,048 other S bills in the 111th — cohort avg 29d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (20)
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2010 · fourth_quarter · Pharmacy
**see addendum page Import Safety H.R. 759 Food and Drug Administration Globalization Act of 2009 S. 510 - FDA Food Safety Modernization Act Importation S. 525/H.R. 1298 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 80 Pharmaceutical Market Access Act of 2009 ***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety
Client expense: Not reported · Firm income: $70,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Pharmacy
**see addendum page Import Safety H.R. 759 Food and Drug Administration Globalization Act of 2009 S. 510 FDA Food Safety Modernization Act Importation S. 525/H.R. 1298 - Pharmaceutical Market Access and Drug Safety Act of 2009 S. 80 - Pharmaceutical Market Access Act of 2009 ***, no specific bill(s), prescription drug importation, import safety
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Pharmacy
**see addendum page **, no specific bill(s), Prescription Drug Importation, Import Safety Import Safety H.R. 759 Food and Drug Administration Globalization Act of 2009 S. 510 FDA Food Safety Modernization Act Importation S. 525/H.R. 1298 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 80 Pharmaceutical Market Access Act of 2009
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Medicare/Medicaid
In support of Drug Reimportation: H.R. 163 and H.R. 1298 and S. 525 and S. 1232 and S. 80, In support of Medicare Part D Improvement: S. 266 and H.R. 3418, In support of Preventing Waste, Fraud and Abuse in Medicare: S. 975 and H.R. 2417
Client expense: $40,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Pharmacy
S 256/HR 2923 - Combat Methamphetamine Enhancement Act of 2010 S 3397/ HR 1359 - Secure and Responsible Drug Disposal Act of 2010 HR 1298/S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 Under Line 17: We would like to include the Office of National Drug Control Policy (ONDCP) HR 5710 - National All Schedules Prescription Electronic Reporting Reauthorization Act of 2010 HAMDT 740 (to HR 5822 Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2010) - a VA prescription drug re-labeling program HR 1204 - The Community Pharmacy Fairness Act of 2009 S 754 - The Methadone Treatment and Protection Act of 2009 HR 2855 - The Drug Overdose Reduction Act HR 163 - Prescription Drug Affordability Act S 80 - Pharmaceutical Market Access Act of 2009 HR 3018 - Amend the Controlled Substance Act to address the use of intrathecal pumps (Docket Number: FDA-2010-N-0001) Third Annual Sentinel Initiative Public Workshop (Docket Number: FDA-2010-N-0128) Prescription Drug User Fee Act; Reopening of the Comment Period (Docket Number: FRL-9197-7) EPA Best Management Practices for Unused Pharmaceuticals at Health Care Facilities (Docket Number: FDA2010N0128) Prescription Drug User Fee Act; Meetings on Reauthorization; Public Meetings (Docket Number FDA-2010-N-0284 and 2009-D-0461) Risk Evaluation and Mitigation Strategies; Notice of Public Meeting; Reopening of Comment Period (Docket Number: DEA-338) Schedules of Controlled Substances: Placement of Propofol Into Schedule IV; Proposed Rule (Docket Number: FDA-2010-N-0273) Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practice Quality System Regulations (Docket No. FDA-2010-N-0344) Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Testing Communications on Medical Devices and Radiation-Emitting Products (Docket Number: FDA2010N0437) Development and Distribution of Patient Medication Information for Prescription Drugs; Public Hearing (Docket Number: FDA-2010-N-0477) Approval Pathway for Biosimilar and Interchangeable Biological Products; Public Hearing; Request for Comments (Docket Number: FDA2010N0486) Safe Use Initiative; Public Workshop; Request for Comments (RIN 0720AB45) DoD Civilian Health and Medical Program of the Uniformed Services (CHAMPUS)/ TRICARE: Inclusion of TRICARE Retail Pharmacy Program in Federal Procurement of Pharmaceuticals (Docket Number: DEA316N) Procedures for the Surrender of Unwanted Controlled Substances by Ultimate Users; Notice of Meeting (Docket Number: DEA 337N) Dispensing of Controlled Substances at Long-Term Care Facilities; Notice, Solicitation of Information (Docket Number: DEA-339S) Role of Authorized Agents in Communicating Controlled Substance Prescriptions to Pharmacies FDA Draft Guidance for Industry and Food and Drug Administration Staff on Dear Health Care Provider Letters: Improving Communication of Important Safety Information Concept Standardizing REMS programs, components and development of a potential tiered REMS System Concept 2010 National Drug Control Strategy (ONDCP)
Client expense: $240,240 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Institutes of Health (NIH), SENATE, White House Office
2010 · fourth_quarter · Medicare/Medicaid
In support of Drug Reimportation: H.R. 163 and H.R. 1298, and S. 525, S. 1232 and S. 80; In support of Medicare Part D Improvement: S. 266 and H.R. 3418; In support of Preventing Waste, Fraud and Abuse in Medicare: S. 975 and H.R. 2417
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Copyright/Patent/Trademark
Access to Affordable Generics (H.R.4899 / S. 369, S.3677) Anti-Counterfeiting and Piracy Legislation (S. 3804) Biosimilars (H.R.1427, H.R.1548, S.726) CJS Appropriations Legislation (S. 3636) Continuing Resolution, PTO Funding (H.R. 3081) Continuing Resolution/Potential Omnibus, PTO Funding (H.R. 3082) Continuing Resolution, PTO Funding (H.J.Res. 105) Copyright Technical Corrections Bill (S. 3689) Design Rights (H.R.3059 / S.1368) Drug Re-Importation (S.80, S.525, H.R.1298) Ending Fee Diversion at USPTO (H.R. 1260, S.515, H.R. 5233) False Patent Marketing Bill Addressing Qui Tam Actions (H.R. 4954/S.515) Fashion Design (H.R. 2196/S.3728) Genetically Modified Crops (H.R. 5579) Hague Agreement Implementation (TBA) Implementation of Patent Law Treaty (TBA) Oil Spill Accountability and Environmental Protection Act (Oberstar) (H.R. 5629) Oil Spill Liability Bill (Conyers) (H.R. 5503) Open Access to the Courts (H.R.4115) Orphan Works Legislation (TBA) Patent Litigation Reform - Sunshine in Litigation Act (H.R. 1508/S.537) Patent Reform (H.R. 1260, S.515, S.610) Patent Specialist Judicial Pilot (H.R.628, S.299, S.515) Pay for Administrative Patent and Trademark Judges (TBA) Repatriation Legislation (H.R. 5980) USPTO Funds for Travel Related Expenses (TBA)
Client expense: $60,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. Customs & Border Protection, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)
2010 · fourth_quarter · Pharmacy
H.R.3590, Patient Protection and Affordable Care Act H.R.4872, Reconciliation Act of 2010 H.R.616/S.511, Access to Durable Medical Equipment Act, related to the exemption of pharmacies from Medicare accreditation requirements. S.525, Pharmaceutical Market Access Act S.1232, Pharmaceutical Market Access and Drug Safety Act H.R.1970/S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009, as related to pharmacy exemption from Medicare Part B regulations. H.R.3108, the Medication Therapy Management Benefits Act, as related to expanded MTM services in the Medicare Part D program. H.R.3663, as related to the delay of pharmacy accreditation requirements under the Medicare DME program. H.R.3962, Affordable Health Care for America Act, as related to the role of pharmacy in healthcare reform, specifically in the Medicare and Medicaid programs. S.256, Combat Methamphetamine Enhancement Act of 2009, as related to the abuse of methamphetamine. S.1490, Personal Data Privacy and Security Act of 2009, as related to provider privacy requirements. H.R.2221, Data Accountability and rust Act, as related to provider privacy requirements. H.R.4489, The Federal Employees Health Benefits Program (FEHBP) Prescription Drug Integrity, Transparency, and Cost Savings Act, as related to pharmacy participation, reimbursement, and disclosure requirements in the FEHBP. S.3000, A bill to extend the increase in the FMAP provided in the American Recovery and Reinvestment Act of 2009 for an additional 6 months, as related to the increase in federal Medicaid matching funds. S.3543, The Medication Therapy Management, MTM, Expanded Benefits Act of 2010. H.R.5136, National Defense Authorization Act for Fiscal Year 2011. S.3454, National Defense Authorization Act for Fiscal Year 2011. H.R.5235, Medicare Access to Diabetes Supplies Act. S.80, Pharmaceutical Market Access Act of 2009. S.511, Access to Durable Medical Equipment Act. S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009.
Client expense: $360,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · third_quarter · Pharmacy
H.R. 3108, Medication Therapy and Management Benefits Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009
Client expense: $110,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · third_quarter · Health Issues
H.R. 1392, to amend Title XVIII of the Social Security Act S. 1221, to amend Title XVIII of the Social Security Act H.R. 759, Food and Drug Administration Globalization Act of 2009 S. 525, a bill to amend the Federal Food, Drug and Cosmetic Act S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 882, Drug and Device Accountability Act of 2009 S. 301, to amend the Title XI of the Social Security Act Health information technology issues
Client expense: $110,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · third_quarter · Pharmacy
H.R. 3108, Medication Therapy and Management Benefits Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · third_quarter · Health Issues
H.R. 1392, to amend Title XVIII of the Social Security Act S. 1221, to amend Title XVIII of the Social Security Act H.R. 759, Food and Drug Administration Globalization Act of 2009 S. 525, a bill to amend the Federal Food, Drug and Cosmetic Act S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 882, Drug and Device Accountability Act of 2009 S. 301, to amend the Title XI of the Social Security Act Health information technology issues
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · third_quarter · Pharmacy
**see addendum page Import Safety H.R. 759 Food and Drug Administration Globalization Act of 2009 S. 510 FDA Food Safety Modernization Act Importation S. 525/H.R. 1298 - Pharmaceutical Market Access and Drug Safety Act of 2009 S. 80 - Pharmaceutical Market Access Act of 2009 ***, no specific bill(s), prescription drug importation, import safety
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Pharmacy
**see addendum page Import Safety H.R. 759 Food and Drug Administration Globalization Act of 2009 S. 510 - FDA Food Safety Modernization Act Importation S. 525/H.R. 1298 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 80 Pharmaceutical Market Access Act of 2009 ***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety
Client expense: Not reported · Firm income: $70,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Pharmacy
H.R.3590, Patient Protection and Affordable Care Act H.R.4872, Reconciliation Act of 2010 H.R.616/S.511, Access to Durable Medical Equipment Act, related to the exemption of pharmacies from Medicare accreditation requirements. S.525, Pharmaceutical Market Access Act S.1232, Pharmaceutical Market Access and Drug Safety Act H.R.1970/S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009, as related to pharmacy exemption from Medicare Part B regulations. H.R.3108, the Medication Therapy Management Benefits Act, as related to expanded MTM services in the Medicare Part D program. H.R.3663, as related to the delay of pharmacy accreditation requirements under the Medicare DME program. H.R.3962, Affordable Health Care for America Act, as related to the role of pharmacy in healthcare reform, specifically in the Medicare and Medicaid programs. S.256, Combat Methamphetamine Enhancement Act of 2009, as related to the abuse of methamphetamine. S.1490, Personal Data Privacy and Security Act of 2009, as related to provider privacy requirements. H.R.2221, Data Accountability and Trust Act, as related to provider privacy requirements. H.R.4489, The Federal Employees Health Benefits Program (FEHBP) Prescription Drug Integrity, Transparency, and Cost Savings Act, as related to pharmacy participation, reimbursement, and disclosure requirements in the FEHBP. S.3000, A bill to extend the increase in the FMAP provided in the American Recovery and Reinvestment Act of 2009 for an additional 6 months, as related to the increase in federal Medicaid matching funds. S.3543, The Medication Therapy Management, MTM, Expanded Benefits Act of 2010. H.R.5136, National Defense Authorization Act for Fiscal Year 2011. S.3454, National Defense Authorization Act for Fiscal Year 2011. H.R.5235, Medicare Access to Diabetes Supplies Act. S.80, Pharmaceutical Market ccess Act of 2009. S.511, Access to Durable Medical Equipment Act S.956, Preserve Patient Access to Reputable DMEPOS Providers Act of 2009.
Client expense: $400,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · third_quarter · Pharmacy
HR 5710 - National All Schedules Prescription Electronic Reporting Reauthorization Act of 2010 S 256/HR 2923 - Combat Methamphetamine Enhancement Act of 2009 S 3397/ HR 1359 - Secure and Responsible Drug Disposal Act of 2010 S 80 - Pharmaceutical Market Access Act of 2009 HR 1298/S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 HAMDT 740 (to HR 5822 Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2010) - a VA prescription drug re-labeling program HR 1204 - The Community Pharmacy Fairness Act of 2009 S 754 - The Methadone Treatment and Protection Act of 2009 HR 2855 - The Drug Overdose Reduction Act HR 163 - Prescription Drug Affordability Act HR 3018 - Amend the Controlled Substance Act to address the use of intrathecal pumps (Docket Number: FDA2010N0184) Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Study of Patient Information Prototypes (Docket Number: FDA2010N0001) Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee; Notice of Meeting on Opioid REMS (Docket Number: FDA2010N0168) Developing Guidance on Naming, Labeling, and Packaging Practices to Reduce Medication Errors; Public Workshop; Request for Comments (Docket Number: FDA2010N0128) Prescription Drug User Fee Act; Meetings on Reauthorization; Public Meetings (Docket Number FDA-2010-N-0284 and 2009-D-0461) Risk Evaluation and Mitigation Strategies; Notice of Public Meeting; Reopening of Comment Period (Docket Number: FDA2010N0437) Development and Distribution of Patient Medication Information for Prescription Drugs; Public Hearing (Docket Number: DEA 337N) Dispensing of Controlled Substances at Long-Term Care Facilities; Notice, Solicitation of Information (Docket Number: DEA-339S) Role of Authorized Agents in Communicating Controlled Substance Prescriptions to Pharmacies DEA National Drug Take-Back Day Concept Standardizing REMS programs, components and development of a potential tiered REMS System
Client expense: $212,859 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)
2010 · third_quarter · Pharmacy
**see addendum page **, no specific bill(s), Prescription Drug Importation, Import Safety Import Safety H.R. 759 Food and Drug Administration Globalization Act of 2009 S. 510 FDA Food Safety Modernization Act Importation S. 525/H.R. 1298 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 80 Pharmaceutical Market Access Act of 2009
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Medicare/Medicaid
In support of Drug Reimportation: H.R. 163 and H.R. 1298 and S. 525 and S. 1232 and S. 80, In support of Medicare Part D Improvement: S. 266 and H.R. 3418, In support of Preventing Waste, Fraud and Abuse in Medicare: S. 975 and H.R. 2417
Client expense: $40,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Medicare/Medicaid
In support of Drug Reimportation: H.R. 163 and H.R. 1268 and S. 525, S. 1232 and S. 80; In support of Medicare Part D Improvement: S. 266 and H.R. 3418; In support of Preventing Waste, Fraud and Abuse in Medicare: S. 975 and H.R. 2417
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Health Issues
General health care issues, including, but not limited to, coverage and reimbursement; drug importation; Pharmaceutical Market Access Act (S.80); Prescription Drug Affordability Act (H.R. 163); the Pharmaceutical Market Access and Drug Safety Act (S. 525)
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Copyright/Patent/Trademark
Access to Affordable Generics (H.R.4899 / S. 369, S.3677) Appropriations Legislation (S. 3636) Biosimilars (H.R.1427, H.R.1548, S.726) Continuing Resolution, PTO Funding (H.R. 3081) Copyright Technical Corrections Bill (S. 3689) Design Rights (H.R.3059 / S.1368) Drug Re-Importation (S.80, S.525, H.R.1298) Ending Fee Diversion at USPTO (H.R. 1260, S.515, H.R. 5233) False Patent Marketing Bill Addressing Qui Tam Actions (H.R. 4954/S.515) Fashion Design (H.R. 2196/S.3728) Genetically Modified Crops (H.R. 5579) Hague Agreement Implementation (TBA) Implementation of Patent Law Treaty (TBA) Oil Spill Accountability and Environmental Protection Act (Oberstar) (H.R. 5629) Oil Spill Liability Bill (Conyers) (H.R. 5503) Open Access to the Courts (H.R.4115) Orphan Works Legislation (TBA) Patent Litigation Reform - Sunshine in Litigation Act (H.R. 1508/S.537) Patent Reform (H.R. 1260, S.515, S.610) Patent Specialist Judicial Pilot (H.R.628, S.299, S.515) Pay for Administrative Patent and Trademark Judges (TBA) Repatriation Legislation (H.R. 5980) USPTO Funds for Travel Related Expenses (TBA)
Client expense: $60,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. Customs & Border Protection, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)
2010 · second_quarter · Copyright/Patent/Trademark
S. 515 Patent Reform Act of 2009 H.R. 1260 Patent Reform Act of 2009 S. 610 Patent Reform Act of 2009 S. 80 Pharmaceutical Market Access Act of 2009 S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
2010 · second_quarter · Health Issues
H.R. 3590, Patient Protection and Affordable Care Act H.R. 4872, Health Care and Education Reconciliation Act of 2010 H.R. 1392, To amend Title XVIII of the Social Security Act S. 1221, To amend Title XVIII of the Social Security Act H.R. 759, Food and Drug Administration Globalization Act of 2009 S. 525, A bill to amend the Federal Food, Drug and Cosmetic Act S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 882, Drug and Device Accountability Act of 2009 S. 301, To amend Title XI of the Social Security Act Health information technology issues
Client expense: $240,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · second_quarter · Pharmacy
H.R. 3590, Patient Protection and Affordable Care Act H.R. 4872, Health Care and Education Reconciliation Act of 2010 H.R. 3108, Medication Therapy and Management Benefits Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009
Client expense: $240,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · second_quarter · Pharmacy
**see addendum page Import Safety H.R. 759 Food and Drug Administration Globalization Act of 2009 S. 510 FDA Food Safety Modernization Act Importation S. 525/H.R. 1298 - Pharmaceutical Market Access and Drug Safety Act of 2009 S. 80 - Pharmaceutical Market Access Act of 2009 ***, no specific bill(s), prescription drug importation, import safety
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Pharmacy
**see addendum page Import Safety H.R. 759 Food and Drug Administration Globalization Act of 2009 S. 510 - FDA Food Safety Modernization Act Importation S. 525/H.R. 1298 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 80 Pharmaceutical Market Access Act of 2009 ***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety
Client expense: Not reported · Firm income: $70,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Consumer Issues/Safety/Products
S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 882 - Drug and Device Accountability Act H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09
Client expense: $2,250,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA)
2010 · second_quarter · Pharmacy
**see addendum page **, no specific bill(s), Prescription Drug Importation, Import Safety Import Safety H.R. 759 Food and Drug Administration Globalization Act of 2009 S. 510 FDA Food Safety Modernization Act Importation S. 525/H.R. 1298 Pharmaceutical Market Access and Drug Safety Act of 2009 S. 80 Pharmaceutical Market Access Act of 2009
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Copyright/Patent/Trademark
HR 1260/S 515/S 610: PATENT REFORM ACT OF 2009; ALL PROVISIONS OF THE BILL S 80 PHARMACEUTICAL MARKET ACCESS ACT OF 2009; ALL PROVISIONS OF THE BILL S 525 PHARMACEUTICAL MARKET ACCESS AND DRUG SAFETY ACT OF 2009; ALL PROVISIONS OF THE BILL
Client expense: $780,000 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
2010 · second_quarter · Pharmacy
HR 1204 - The Community Pharmacy Fairness Act of 2009 S 80 - Pharmaceutical Market Access Act of 2009 HR 1298/S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 SRes 539 - A resolution designating May 24, 2010, as "Prescription Drug Disposal Awareness Day S 256 - Combat Methamphetamine Enhancement Act of 2009 S 754 - The Methadone Treatment and Protection Act of 2009 HR 2855 - The Drug Overdose Reduction Act HR 163 - Prescription Drug Affordability Act HR 3018 - Amend the Controlled Substance Act to address the use of intrathecal pumps (Docket Number: FDA2010N0184) Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Study of Patient Information Prototypes (Docket Number: FDA2010N0001) Drug Safety and Risk Management Advisory Committee; Notice of Meeting (Docket Number: FDA-2009-N-0247) FDA Transparency Initiative: Draft Proposals for Public Comment Regarding Disclosure Policies of the U.S. Food and Drug Administration; Availability (Docket Number: FDA2010N0168) Developing Guidance on Naming, Labeling, and Packaging Practices to Reduce Medication Errors; Public Workshop; Request for Comments (Docket Number: FDA2010N0128) Prescription Drug User Fee Act; Meetings on Reauthorization; Public Meetings (Docket Number FDA2009D0461) FDA Draft Guidance for Industry: Format and Content of Proposed Risk Evaluation and Mitigation Strategies (REMS), REMS Assessments, and Proposed REMS Modifications (Docket Number: FDA-2008-P-0380) Citizen Petition: Requesting a FDA Action on a "One Document Solution" for all pharmacy-based communications (Docket Number: FDA2009N0143) Risk Evaluation and Mitigation Strategies for Certain Opioid Drugs; Notice of Public Meeting (Docket Number: FDA-2010-N-0001) Pharmaceutical Supply Chain; Public Workshop (Docket Number: DEA-218I) Electronic Prescriptions for Controlled Substances; Final Rule (Docket Number: FDA-2009-N-0582) Direct-to-Consumer Prescription Drug Advertisements; Presentation of the Major Statement in Television and Radio Advertisements in a Clear, Conspicuous, and Neutral Manner (Docket Number: FDA-2010-N-0136) Request for Comment on Implementation of the Family Smoking Prevention and Tobacco Control Act (Docket Number: DEA-328P) Implementation of the Methamphetamine Production Prevention Act of 2008 (Docket Number: FDA2010N0001) Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee; Notice of Meeting (Opioid REMS) (Docket Number: FDA-2010-N-0284, FDA-2009-D-0461) Risk Evaluation and Mitigation Strategies; Notice of Public Meeting (Docket Number: FDA-2009-D-0001) Guidance for Industry on Standards for Securing the Drug Supply Chain--Standardized Numerical Identification for Prescription Drug Packages; Availability ONDCPs 2010 National Drug Control Policy FDA Safe Use Initiative Concept - Reauthorization of Prescription Drug User Fee Act Concept - DEA Agent of the Prescriber Concept - Oppose Liberalizing Prescription Drug Importation
Client expense: $151,510 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, White House Office
2010 · second_quarter · Medicare/Medicaid
In support of Drug Reimportation: H.R. 163 and H.R. 1298 and S.525, S. 1232, S. 80; In support of Medicare Part D Improvement: S. 266 and H.R. 3418; In support of Preventing Waste, Fraud, and Abuse in Medicare: S. 975; In support of Removing Social Security Numbers from Medicare Cards: H.R. 2417
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Pharmacy
H.R. 3590, Patient Protection and Affordable Care Act H.R. 4872, Health Care and Education Reconciliation Act of 2010 H.R. 3108, Medication Therapy and Management Benefits Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · second_quarter · Health Issues
H.R. 3590, Patient Protection and Affordable Care Act H.R. 4872, Health Care and Education Reconciliation Act of 2010 H.R. 1392, To amend Title XVIII of the Social Security Act S. 1221, To amend Title XVIII of the Social Security Act H.R. 759, Food and Drug Administration Globalization Act of 2009 S. 525, A bill to amend the Federal Food, Drug and Cosmetic Act S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 882, Drug and Device Accountability Act of 2009 S. 301, To amend Title XI of the Social Security Act Health information technology issues
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · second_quarter · Medicare/Medicaid
In support of Drug Reimportation: H.R. 163 and H.R. 1298 and S. 525 and S. 1232 and S. 80, In support of Medicare Part D Improvement: S. 266 and H.R. 3418, In support of Preventing Waste, Fraud and Abuse in Medicare: S. 975 and H.R. 2417
Client expense: $40,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Health Issues
General Healthcare issues, including but not limited to, coverage and reimbursement, drug importation; Pharmaceutical Market Access Act (S.80); Prescription Drug Affordability Act (H.R. 163); The Pharmaceutical Market Access and Drug Safety Act (S. 525)
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Copyright/Patent/Trademark
Access to Affordable Generics (H.R.4899 / S. 369) Biosimilars (H.R.1427, H.R.1548, S.726) Design Rights (H.R.3059 / S.1368) Drug Re-Importation (S.80, S.525, H.R.1298) Ending Fee Diversion at USPTO (H.R. 1260, S.515) False Patent Marketing Bill Addressing Qui Tam Actions (H.R. 4954/S.515) Fashion Design (H.R. 2196) Genetically Modified Crops (H.R. 5579) Hague Agreement Implementation (TBA) Implementation of Patent Law Treaty (TBA) Oil Spill Accountability and Environmental Protection Act (Oberstar) (H.R. 5629) Oil Spill Liability Bill (Conyers) (H.R. 5503) Open Access to the Courts (H.R.4115) Orphan Works Legislation (TBA) Patent Litigation Reform - Sunshine in Litigation Act (H.R. 1508/S.537) Patent Reform (H.R. 1260, S.515, S.610) Patent Specialist Judicial Pilot (H.R.628, S.299, S.515) Pay for Administrative Patent and Trademark Judges (TBA) USPTO Funds for Travel Related Expenses (TBA)
Client expense: $100,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. Customs & Border Protection, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)
2010 · first_quarter · Copyright/Patent/Trademark
Biosimilars (H.R.1427, H.R.1548, S.726) Design Rights (H.R.3059 / S.1368) Drug Re-Importation (S.80, S.525, H.R.1298) Ending Fee Diversion at USPTO (H.R. 1260, S.515) False Patent Marketing Bill Addressing Qui Tam Actions (H.R. 4954) Hague Agreement Implementation (TBA) Implementation of Patent Law Treaty (TBA) Orphan Works Legislation (TBA) Patent Litigation Reform - Sunshine in Litigation Act (H.R. 1508/S.537) Patent Reform (H.R. 1260, S.515, S.610) Patent Specialist Judicial Pilot (H.R.628, S.299, S.515) Pay for Administrative Patent and Trademark Judges (TBA) Trademark Technical and Conforming Amendment Act of 2010 (S. 2968) USPTO Funds for Travel Related Expenses (TBA)
Client expense: $60,000 · Firm income: Not reported
Government targets: Commerce, Dept of (DOC), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE, U.S. Copyright Office, U.S. Customs & Border Protection, U.S. International Trade Commission (ITC), U.S. Trade Representative (USTR)
2010 · first_quarter · Health Issues
H.R. 3590, Patient Protection and Affordable Care Act H.R. 4872, Health Care and Education Reconciliation Act of 2010 H.R. 1392, To amend title XVIII of the Social Security Act S. 1221, To amend title XVIII of the Social Security Act H.R. 759, Food and Drug Administration Globalization Act of 2009 S. 525, A bill to amend the Federal Food, Drug, and Cosmetic Act S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 882, Drug and Device Accountabilit Act of 2009 S. 301, to amend title XI of the Social Security Act
Client expense: $433,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · first_quarter · Pharmacy
H.R. 3590, Patient Protection and Affordable Care Act H.R. 4872, Health Care and Education Reconciliation Act of 2010 H.R. 3108, Medication Therapy and Management Benefits Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009
Client expense: $433,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · first_quarter · Copyright/Patent/Trademark
HR 1260/S 515/S 610: PATENT REFORM ACT OF 2009; ALL PROVISIONS OF THE BILL S 80 PHARMACEUTICAL MARKET ACCESS ACT OF 2009; ALL PROVISIONS OF THE BILL S 525 PHARMACEUTICAL MARKET ACCESS AND DRUG SAFETY ACT OF 2009; ALL PROVISIONS OF THE BILL
Client expense: $700,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
2010 · first_quarter · Pharmacy
**see addendum page **, no specific bill(s), Prescription Drug Importation, Import Safety Import Safety H.R. 759 - Food and Drug Administration Globalization Act of 2009 S. 510 - FDA Food Safety Modernization Act Importation S. 525/H.R. 1298 - Pharmaceutical Market Access and Drug Safety Act of 2009 S. 80 - Pharmaceutical Market Access Act of 2009 H.R. 3590 - The Patient Protection and Affordable Care Act
Client expense: Not reported · Firm income: $50,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Consumer Issues/Safety/Products
S.80 - Pharmaceutical Market Access Act, 1/09 S. 501 - Fair prescription Drug Competition Act, 3/09 S. 882 - Drug and Device Accountability Act H.R. 573 - act to prohibit the marketing of authorized generic drugs, 1/09 H.R. 1427 - Promoting Innovation and Access to Life-Saving Medicines Act, 3/09 H.R. 1548 - Pathway for Biosimilars Act, 3/09 H.R. 759 - The Food, drug and Cosmetic Globalization Act, 1/09 H.R. 1259 - Dextromethorphan Distribution Act 4/09 S. 1383 - Dextromethorphan Abuse Reduction Act 6/09
Client expense: $4,340,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Defense, Dept of (DOD), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), Veterans Affairs, Dept of (VA)
2010 · first_quarter · Pharmacy
**see addendum page Import Safety H.R. 759 - Food and Drug Administration Globalization Act of 2009 S. 510 - FDA Food Safety Modernization Act Importation S. 525/H.R. 1298 - Pharmaceutical Market Access and Drug Safety Act of 2009 S. 80 - Pharmaceutical Market Access Act of 2009 H.R. 3590 - The Patient Protection and Affordable Care Act ***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety
Client expense: Not reported · Firm income: $70,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Pharmacy
S 754 - The Methadone Treatment and Protection Act of 2009 HR 2855 - The Drug Overdose Reduction Act S 256 - Combat Methamphetamine Enhancement Act of 2009 HR 1706 - Protecting Consumer Access to Generic Drugs Act of 2009 HR 3018 - Amend the Controlled Substance Act to address the use of intrathecal pumps HR 1204 - The Community Pharmacy Fairness Act of 2009 S 80 - Pharmaceutical Market Access Act of 2009 HR 1298/S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 HR 163 - Prescription Drug Affordability Act (Docket Number FDA2009D0461) FDA Draft Guidance for Industry: Format and Content of Proposed Risk Evaluation and Mitigation Strategies (REMS), REMS Assessments, and Proposed REMS Modifications (Docket Number FDA2008N0038) Risk Communication Advisory Committee; Notice of Meeting on the types of communications that patients receive at the pharmacy including: medication guides; patients package inserts; and consumer medication information (Docket Number: FDA-2008-P-0380) Citizen Petition: Requesting a FDA Action on a "One Document Solution" for all pharmacy-based communications (Docket Number: FDA2009N0295) Providing Effective Information to Consumers About Prescription Drug Risks and Benefits; Public Workshop (Docket Number: FDA2009N0143) Risk Evaluation and Mitigation Strategies for Certain Opioid Drugs; Notice of Public Meeting (Docket Number: FDA2009N0247) Food and Drug Administration Transparency Task Force; Request for Comments (Docket Number: DEA321) Identification of Institution-based Individual Practitioners (Docket Number: FDA-2009-D-0001) Guidance for Industry on Standards for Securing the Drug Supply Chain--Standardized Numerical Identification for Prescription Drug Packages; Availability (Docket Number: FDA2010N0128) Prescription Drug User Fee Act; Public Meeting (Docket Number: DEA-218I) Electronic Prescriptions for Controlled Substances; Final Rule (Docket Number: FDA2004N0449) (formerly Docket Number: 2004N0439) Current Good Manufacturing Practice for Positron Emission Tomography Drugs Notice Regarding 340B Drug Pricing ProgramContract Pharmacy Services Concept - Medication Adherence Concept - Pharmacogenomics Concept - DEA Agent of the Prescriber Concept - Oppose Liberalizing Prescription Drug Importation
Client expense: $149,615 · Firm income: Not reported
Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), SENATE, White House Office
2010 · first_quarter · Pharmacy
**see addendum page Import Safety H.R. 759 - Food and Drug Administration Globalization Act of 2009 S. 510 - FDA Food Safety Modernization Act Importation S. 525/H.R. 1298 - Pharmaceutical Market Access and Drug Safety Act of 2009 S. 80 - Pharmaceutical Market Access Act of 2009 H.R. 3590 - The Patient Protection and Affordable Care Act ***, no specific bill(s), prescription drug importation, import safety
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Health Issues
General Healthcare issues, including but not limited to, coverage and reimbursement, drug importation; Pharmaceutical Market Access Act (S.80); Prescription Drug Affordability Act (H.R. 163); The Pharmaceutical Market Access and Drug Safety Act (S. 525)
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · first_quarter · Copyright/Patent/Trademark
S. 515 Patent Reform Act of 2009 H.R. 1260 Patent Reform Act of 2009 S. 610 Patent Reform Act of 2009 S. 80 Pharmaceutical Market Access Act of 2009 S. 525 Pharmaceutical Market Access and Drug Safety Act of 2009
Client expense: Not reported · Firm income: $60,000
Government targets: HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
2010 · first_quarter · Health Issues
H.R. 3590, Patient Protection and Affordable Care Act H.R. 4872, Health Care and Education Reconciliation Act of 2010 H.R. 1392, To amend title XVIII of the Social Security Act S. 1221, To amend title XVIII of the Social Security Act H.R. 759, Food and Drug Administration Globalization Act of 2009 S. 525, A bill to amend the Federal Food, Drug, and Cosmetic Act S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 882, Drug and Device Accountabilit Act of 2009 S. 301, to amend title XI of the Social Security Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · first_quarter · Pharmacy
H.R. 3590, Patient Protection and Affordable Care Act H.R. 4872, Health Care and Education Reconciliation Act of 2010 H.R. 3108, Medication Therapy and Management Benefits Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · first_quarter · Medicare/Medicaid
In support of Drug Reimportation: H.R. 163 and H.R. 1298 and S. 525, S. 80 and S. 1232; In support of Medicare Part D Improvement: S. 266 and H.R. 3418; In support of Preventing Waste, Fraud, and Abuse in Medicare: S. 975
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE